| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |